There is discrepancy in the phenotypic manifestations of trimethylaminuria (TMAU) between patients suggesting a certain diversity of etiological-pathogenic factors. Primary TMAU is linked to mutations in the FMO3 gene but a proportion of patients do not carry mutations in it or carry single nucleotide polymorphisms (SNPs) that do not have an impact on the gene’s product, the enzyme FMO3. It remains to be established what other factors are pathogenic in TMAU underpinning the various phenotypes. We hypothesized that defective chaperones could contribute to the pathogenesis by, for example, failing to assist FMO3 in its folding and refolding cycles. In the initial screening reported here we investigated two chaperone genes, HSPA8 and HSPA1A in twelve TMAU patients and found that variants in the former were highly represented in comparison with controls. Further studies, including more patients are underway to firmly establish the prevalence of the variants and to begin elucidating molecular mechanisms.

VARIANTS OF THE MOLECULAR CHAPERONE HSPA8 AND HSPA1A GENES IN TRIMETHYLAMINURIA: A PILOT STUDY

Concetta Scimone;Simona Alibrandi;Luigi Donato
;
Antonina Sidoti;Rosalia D’Angelo
2020-01-01

Abstract

There is discrepancy in the phenotypic manifestations of trimethylaminuria (TMAU) between patients suggesting a certain diversity of etiological-pathogenic factors. Primary TMAU is linked to mutations in the FMO3 gene but a proportion of patients do not carry mutations in it or carry single nucleotide polymorphisms (SNPs) that do not have an impact on the gene’s product, the enzyme FMO3. It remains to be established what other factors are pathogenic in TMAU underpinning the various phenotypes. We hypothesized that defective chaperones could contribute to the pathogenesis by, for example, failing to assist FMO3 in its folding and refolding cycles. In the initial screening reported here we investigated two chaperone genes, HSPA8 and HSPA1A in twelve TMAU patients and found that variants in the former were highly represented in comparison with controls. Further studies, including more patients are underway to firmly establish the prevalence of the variants and to begin elucidating molecular mechanisms.
2020
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/3210212
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact